Literature DB >> 28367877

Minocycline Inhibits Candida albicans Budded-to-Hyphal-Form Transition and Biofilm Formation.

Sanae Kurakado1, Kazuhiko Takatori2, Takashi Sugita1.   

Abstract

Candida albicans frequently causes bloodstream infections; its budded-to-hyphalform transition (BHT) and biofilm formation are major contributors to virulence. During an analysis of antibacterial compounds that inhibit C. albicans BHT, we found that the tetracycline derivative minocycline inhibited BHT and subsequent biofilm formation. Minocycline decreased expression of hypha-specific genes HWP1 and ECE1, and adhesion factor gene ALS3 of C. albicans. In addition, minocycline decreased cell surface hydrophobicity and the extracellular β-glucan level in biofilms. Minocycline has been widely used for catheter antibiotic lock therapy to prevent bacterial infection; this compound may also be prophylactically effective against Candida infection.

Entities:  

Keywords:  Candida albicans; biofilm; budded-to-hyphal-form transition (BHT); minocycline; β-1,3-glucan

Mesh:

Substances:

Year:  2017        PMID: 28367877     DOI: 10.7883/yoken.JJID.2016.369

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  3 in total

1.  Culture Supernatants of Lactobacillus gasseri and L. crispatus Inhibit Candida albicans Biofilm Formation and Adhesion to HeLa Cells.

Authors:  Yuko Matsuda; Otomi Cho; Takashi Sugita; Daiki Ogishima; Satoru Takeda
Journal:  Mycopathologia       Date:  2018-03-30       Impact factor: 2.574

Review 2.  Role of Cell Surface Hydrophobicity in the Pathogenesis of Medically-Significant Fungi.

Authors:  Carina Danchik; Arturo Casadevall
Journal:  Front Cell Infect Microbiol       Date:  2021-01-25       Impact factor: 5.293

3.  The synergistic effect of minocycline and azole antifungal drugs against Scedosporium and Lomentospora species.

Authors:  Fang Yang; Yi Sun; Qiaoyun Lu
Journal:  BMC Microbiol       Date:  2022-01-12       Impact factor: 3.605

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.